Literature DB >> 11735489

Synthesis of enantiopure oxorhenium(V) and arylimidorhenium(V) "3 + 2" Schiff base complexes. X-ray diffraction, cyclic voltammetry, UV-vis, and circular dichroism characterizations.

V M Béreau1, S I Khan, M M Abu-Omar.   

Abstract

Two new oxorhenium(V) and two new arylimidorhenium(V) complexes of the Schiff base ligands 2-hydroxybenzaldehyde-((1R,2S)-1-amino-2-indanol)imine (1) (H(2)L(1)) and 3-(1-adamantyl)-2-hydroxy-5-methylbenzaldehyde-((1R,2S)-1-amino- 2-indanol)imine (2) (H(2)L(2)) have been prepared from the reaction of the precursor Re(O)(PPh(3))(2)Cl(3), Re(NC(6)H(5))(PPh(3))(2)Cl(3), or Re(NC(6)H(4)OCH(3))(PPh(3))(2)Cl(3) and the free ligands H(2)L(1,2). The complexes Re(O)(HL(1))(L(1)) (3), Re(O)(HL(2))(L(2)) (4), Re(NC(6)H(5))(HL(1))(L(1)) (5), and Re(NC(6)H(4)OCH(3))(HL(1))(L(1)) (6) have been isolated and fully characterized by IR, (1)H NMR, circular dichroism, LRMS-FAB, and elemental analysis. All the complexes have a chiral center at rhenium. A single enantiomer is obtained in all cases. Suitable crystals of 3 and 5 were used in X-ray structural determinations. Crystal data: (3) C(32)H(27)N(2)O(5)Re.CH(2)Cl(2), orthorhombic, P2(1)2(1)2(1), a = 9.5599(16) A, b = 9.9579(16) A, c = 31.712(5) A, V = 3018.9(9) A(3), T = 100(2) K, Z = 4. (5) C(40)H(38)N(3)O(5)Re, monoclinic, P2(1), a = 9.286(3) A, b = 18.759(6) A, c = 9.957(3) A, beta = 102.817(6) degrees, V = 1691.3(10) A(3), T = 100(2) K, Z = 2. The major characteristic of these complexes is the presence of two coordination modes for the Schiff base ligands on rhenium, a tridentate ligand (noted L(1,2)) and another bidentate ligand (noted HL(1,2)). In the latter, the -OH group of the indanol is free and tilts away from the coordination sphere. X-ray structural analyses in conjunction with circular dichroism were used to assign the absolute configuration at rhenium (C). Cyclic voltammetry, UV-vis, and circular dichroism data are presented and discussed. The complexes were found to be highly stable and to resist reduction even when treated with organic phosphanes.

Entities:  

Year:  2001        PMID: 11735489     DOI: 10.1021/ic0108033

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Re(V) and Re(III) complexes with sal2phen and triphenylphosphine: rearrangement, oxidation and reduction.

Authors:  Stephanie Renee Lane; Nebiat Sisay; Brett Carney; Shorouk Dannoon; Stephen Williams; Hendrik Petrus Engelbrecht; Charles Leslie Barnes; Silvia Sabine Jurisson
Journal:  Dalton Trans       Date:  2010-11-15       Impact factor: 4.390

2.  Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.

Authors:  Vanessa A Sanders; David Iskhakov; Dalya Abdel-Atti; Matthew Devany; Michelle C Neary; Ken R Czerwinski; Lynn C Francesconi
Journal:  Nucl Med Biol       Date:  2018-11-12       Impact factor: 2.408

3.  Novel rhenium(III, IV, and V) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes.

Authors:  David A Rotsch; Kimberly M Reinig; Eric M Weis; Anna B Taylor; Charles L Barnes; Silvia S Jurisson
Journal:  Dalton Trans       Date:  2013-07-04       Impact factor: 4.390

4.  N-Centered Tripodal Phosphine Re(V) and Tc(V) Oxo Complexes: Revisiting a [3 + 2] Mixed-Ligand Approach.

Authors:  Saul M Cooper; Andrew J P White; Thomas R Eykyn; Michelle T Ma; Philip W Miller; Nicholas J Long
Journal:  Inorg Chem       Date:  2022-05-11       Impact factor: 5.436

5.  MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.

Authors:  Melchor V Cantorias; Robertha C Howell; Louis Todaro; John E Cyr; Dietmar Berndorff; Robin D Rogers; Lynn C Francesconi
Journal:  Inorg Chem       Date:  2007-08-11       Impact factor: 5.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.